National Patient Safety Alert – risk of oxytocin overdose during labour and childbirth

A National Patient Safety Alert has been issued by the NHS England National Patient Safety team, endorsed by the Royal College of Obstetricians and Gynaecologists, Royal College of Midwives and Royal College of Anaesthetists, instructing all relevant NHS funded maternity care providers to cease pre-preparing oxytocin infusions at ward level in all clinical areas.

Oxytocin is one of the most commonly utilised drugs in labour and childbirth. An oxytocin infusion can be administered to augment contractions during labour or in a much higher dose to treat postpartum haemorrhage. The inadvertent administration of a postnatal dose of oxytocin prior to the birth of the baby can lead to significant harm to mother and baby.

To reduce the risk of harm and inadvertent administration, NHS trusts should no longer pre-prepare oxytocin infusions at ward level, that will be administered either via infusion pumps or syringe pumps, in anticipation of its use.

To minimise any theoretical risks of delayed treatment of postpartum haemorrhage, the immediate availability of trolleys/kits is advised. Local guidelines/policies should be updated accordingly.

This National Patient Safety Alert instructs all relevant NHS funded organisations providing maternity care to cease pre-preparing oxytocin infusions at ward level in all clinical areas. All actions should be completed by 31 March 2025.​

Failure to take the actions required under any National Patient Safety Alert may lead to CQC taking regulatory action. 

To view the alert visit: 

Latest Issues

CSC Autumn Study Day 2024

Crowne Plaza Birmingham NEC
14th October 2024

BAUN 2024 Annual Conference

ACC, Liverpool
3rd - 5th November 2024

The AfPP Roadshow - Belfast

ICC Belfast
9th November 2024

IDSc Annual Conference 2024

Hilton Birmingham Metropole Hotel
26th - 27th November 2024

IV Forum 2024

Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024

The AfPP Roadshow - Leeds

TBA, Leeds
7th December 2024